These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 16455164)

  • 21. Ovine ceroid-lipofuscinosis: a model of Batten's disease.
    Jolly RD; Janmaat A; West DM; Morrison I
    Neuropathol Appl Neurobiol; 1980; 6(3):195-209. PubMed ID: 6772982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ceroid, lipofuscin and the ceroid-lipofuscinoses (Batten disease).
    Jolly RD; Dalefield RR; Palmer DN
    J Inherit Metab Dis; 1993; 16(2):280-3. PubMed ID: 8411981
    [No Abstract]   [Full Text] [Related]  

  • 23. Glycoconjugates in storage cytosomes from ceroid-lipofuscinosis (Batten's disease) and in lipofuscin from old-age brain.
    Hall NA; Lake BD; Palmer DN; Jolly RD; Patrick AD
    Adv Exp Med Biol; 1989; 266():225-41; discussion 242. PubMed ID: 2486152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondrial damage results in a reversible increase in lysosomal storage material in lymphoblasts from patients with juvenile neuronal ceroid-lipofuscinosis (Batten Disease).
    Boriack RL; Cortinas E; Bennett MJ
    Am J Med Genet; 1995 Jun; 57(2):301-3. PubMed ID: 7668350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The aging myocardium: roles of mitochondrial damage and lysosomal degradation.
    Terman A; Brunk UT
    Heart Lung Circ; 2005 Jun; 14(2):107-14. PubMed ID: 16352265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and 'aggresomes' during oxidative stress, aging, and disease.
    Grune T; Jung T; Merker K; Davies KJ
    Int J Biochem Cell Biol; 2004 Dec; 36(12):2519-30. PubMed ID: 15325589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catabolic insufficiency and aging.
    Terman A
    Ann N Y Acad Sci; 2006 May; 1067():27-36. PubMed ID: 16803967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging new roles of the lysosome and neuronal ceroid lipofuscinoses.
    Mukherjee AB; Appu AP; Sadhukhan T; Casey S; Mondal A; Zhang Z; Bagh MB
    Mol Neurodegener; 2019 Jan; 14(1):4. PubMed ID: 30651094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developmental impairments of select neurotransmitter systems in brains of Cln3(Deltaex7/8) knock-in mice, an animal model of juvenile neuronal ceroid lipofuscinosis.
    Herrmann P; Druckrey-Fiskaaen C; Kouznetsova E; Heinitz K; Bigl M; Cotman SL; Schliebs R
    J Neurosci Res; 2008 Jun; 86(8):1857-70. PubMed ID: 18265413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular models of Batten disease.
    Minnis CJ; Thornton CD; FitzPatrick LM; McKay TR
    Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165559. PubMed ID: 31655107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autophagy, proteasomes, lipofuscin, and oxidative stress in the aging brain.
    Keller JN; Dimayuga E; Chen Q; Thorpe J; Gee J; Ding Q
    Int J Biochem Cell Biol; 2004 Dec; 36(12):2376-91. PubMed ID: 15325579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protease inhibitors as a model for NCL disease, with special emphasis on the infantile and adult forms.
    Ivy GO
    Am J Med Genet; 1992 Feb; 42(4):555-60. PubMed ID: 1376968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysosomal dysfunction, autophagic defects, and CLN5 accumulation underlie the pathogenesis of KCTD7-mutated neuronal ceroid lipofuscinoses.
    Wang Y; Wang H; Wang C
    Autophagy; 2023 Jun; 19(6):1876-1878. PubMed ID: 36368077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-related accumulation of ceroid-like pigment in mice with Chediak-Higashi syndrome.
    Oliver C; Essner E; Zimring A; Haimes H
    Am J Pathol; 1976 Aug; 84(2):225-38. PubMed ID: 941977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human and rat brain lipofuscin proteome.
    Ottis P; Koppe K; Onisko B; Dynin I; Arzberger T; Kretzschmar H; Requena JR; Silva CJ; Huston JP; Korth C
    Proteomics; 2012 Aug; 12(15-16):2445-54. PubMed ID: 22707227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Batten's disease: clues to neuronal protein catabolism in lysosomes.
    Dawson G; Cho S
    J Neurosci Res; 2000 Apr; 60(2):133-40. PubMed ID: 10740217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lectin histochemical study of lipopigments: results with concanavalin A.
    Elleder M; Goebel HH; Koppang N
    Adv Exp Med Biol; 1989; 266():243-58. PubMed ID: 2518593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The evaluation of autofluorescence emission spectra derived from neuronal lipopigment.
    Dowson JH
    J Microsc; 1982 Dec; 128(Pt 3):261-70. PubMed ID: 7154059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The neuronal ceroid-lipofuscinoses (Batten disease): a new class of lysosomal storage diseases.
    Bennett MJ; Hofmann SL
    J Inherit Metab Dis; 1999 Jun; 22(4):535-44. PubMed ID: 10407785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoreactivity of ceroid lipofuscin storage pigment in Batten disease with monoclonal antibodies to the amyloid beta-protein.
    Wisniewski KE; Maslinska D
    N Engl J Med; 1989 Jan; 320(4):256-7. PubMed ID: 2911317
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.